Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Leila
Leila Adamyan, Moscow RU
| Patent application number | Description | Published |
|---|---|---|
| 20120330224 | GAS CONDITIONING - A compound for the manufacturing of a medicament for reducing or preventing mesothelial cell damage includes a mixture of a carrier gas and between 1 volume percent and 29 volume percent of nitrous oxide gas (N | 12-27-2012 |
Leila Asgharnejad, Tehran IR
| Patent application number | Description | Published |
|---|---|---|
| 20100294728 | PREPARATION OF NANOSIZED COMPOUND ZNO/SNO2 PHOTOCATALYSTS - The various embodiments herein provide a method of preparation nanosized amorphous compound ZnO/SnO2 photocatalysts. According to one embodiment herein, the nanosized amorphous compound ZnO/SnO2 photocatalysts are synthesized through coprecipitation method using NaOH as coprecipitant. According to one embodiment herein, nanosized amorphous compound ZnO/SnO2 photocatalysts are synthesized also by another method with molar ratio of 2:1 in ethanol solvent. Nanosized compound ZnO/SnO | 11-25-2010 |
Leila Bahreinian, Santa Clara, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110054589 | STENT WITH VARIABLE CROSS SECTION BRAIDING FILAMENT AND METHOD FOR MAKING SAME - A braided stent comprises a filament having at least one circular zone and at least two non-circular zones. Embodiments of the braided stent have a proximal segment, a middle segment, and a distal segment, wherein a porosity of the middle segment is lower than, a respective porosity of the proximal and distal segments. In one embodiment, a radial pressure of the middle segment is separately controlled to be different from, e.g., less than, a radial pressure of the distal segment. In another embodiment, a stiffness of the middle segment is separately controlled to be different from, e.g., less than, a stiffness of the distal segment. | 03-03-2011 |
Leila Bekraoui, Muenchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100328168 | Vehicle Pane With at Least One Heating Conductor and at Least One Antenna - A vehicle pane exhibits a heating conductor field with at least one heating conductor and at least one antenna, wherein the at least one antenna is mounted on an area of the vehicle pane that is free with respect to the heating conductor field and wherein the heating conductor field has the basic shape of an essentially angular sector. The vehicle pane can also have bus bars for supplying power to at least one heating conductor, the bus bars being arranged on a common edge of the vehicle pane. | 12-30-2010 |
Leila Bossy-Nobs, Geneve CH
| Patent application number | Description | Published |
|---|---|---|
| 20090130176 | INTRAOCULAR LENS WITH DRUG DELIVERY SYSTEM ATTACHED THERETO - The present invention relates to a device comprising an intraocular lens and a drug delivery system attached thereto, wherein said drug delivery system is or can be loaded with one or more therapeutic agents. Preferably, said drug delivery system comprises a biodegradable matrix material wherein said biodegradable matrix material is preferably selected from the group consisting of: poly(lactic acid), poly(glycolic acid), poly(lactide-co-glycolide), polycaprolactones, polyorthoesters, polyanhydrides, polyesteramides and mixtures thereof. Preferred therapeutic agent(s) is/are selected from anti-inflammatory agents, anti-vasoproliferative agents, immunosuppressive agents, antibiotics, antiviral agents, anti-mitotic agents and combinations thereof. Also provided is a method of treatment and/or prevention of one or more diseases or malfunctions of the eye, comprising implanting one, two, three or more devices of the invention into an eye of a patient. | 05-21-2009 |
Leila Cuttle, Queensland AU
| Patent application number | Description | Published |
|---|---|---|
| 20090130070 | METHOD OF TREATMENT - The present invention discloses the use of fetuin and fetuin producing agents in methods and compositions for treating burn injuries in animals. | 05-21-2009 |
Leila Fiouzi, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20090023463 | SYSTEM AND METHOD FOR IMPLEMENTING A UNIVERSAL MESSAGING GATEWAY (UMG) - The system and method for implementing a Universal Messaging Gateway (UMG) disclosed herewith provides telecommunications Network Operators (NO) and like related parties with innovative and flexible art for delivering domestic and foreign network originated Multi-Media traffic and/or, more generally, interactive and/or synchronous mobile text and related telecommunications messaging or information services to a large number of related receiving telecommunications network equipment (as ESMEs and/or SMS-Cs in relation to SMS traffic). | 01-22-2009 |
| 20100203910 | SYSTEM AND METHOD FOR IMPLEMENTING A UNIVERSAL MESSAGING GATEWAY (UMG) - The system and method for implementing a Universal Messaging Gateway (UMG) disclosed herewith provides telecommunications Network Operators (NO) and like related parties with innovative and flexible art for delivering domestic and foreign network originated Multi-media traffic and/or, more generally, interactive and/or synchronous mobile text and related telecommunications messaging or information services to a large number of related receiving telecommunications network equipment (as ESMEs and/or SMS-Cs in relation to SMS traffic). | 08-12-2010 |
| 20110306369 | System and Method for Implementing a Universal Messaging Gateway (UMG) - The system and method for implementing a Universal Messaging Gateway (UMG) disclosed herewith provides telecommunications Network Operators (NO) and like related parties with innovative and flexible art for delivering domestic and foreign network originated Multi-media traffic and/or, more generally, interactive and/or synchronous mobile text and related telecommunications messaging or information services to a large number of related receiving telecommunications network equipment (as ESMEs and/or SMS-Cs in relation to SMS traffic). | 12-15-2011 |
| 20120282957 | SYSTEM AND METHOD FOR IMPLEMENTING A UNIVERSAL MESSAGING GATEWAY (UMG) - The system and method for implementing a Universal Messaging Gateway (UMG) disclosed herewith provides telecommunications Network Operators (NO) and like related parties with innovative and flexible art for delivering domestic and foreign network originated Multi-media traffic and/or, more generally, interactive and/or synchronous mobile text and related telecommunications messaging or information services to a large number of related receiving telecommunications network equipment (as ESMEs and/or SMS-Cs in relation to SMS traffic). | 11-08-2012 |
Leila Hercouet, Neuily Plaisance FR
| Patent application number | Description | Published |
|---|---|---|
| 20130019414 | HAIR TREATMENT PROESS USING A DIRECT EMULSION COMPRISING AN OXIDIZING AGENT AND A DIRECT EMULSION CONTAINING AN ALKALINE AGENT - The subject of the present invention is therefore a method for the lightening and/or lightening dyeing of keratin materials, which consists in treating the keratin fibres with at least: a) one direct emulsion (A) comprising one or more fatty substances free of carboxylic acid groups, one or more surfactants, an amount of water of greater than 5% by weight of the total weight of the emulsion, and one or more oxidizing agents; and b) one direct emulsion (B) comprising one or more fatty substances free of carboxylic acid groups, one or more surfactants, an amount of water of greater than 5% by weight of the total weight of the emulsion, and one or more alkaline agents; the concentration of fatty substances free of carboxylic acid groups being at least equal to 25% by weight of the total weight of the composition obtained after mixing the two direct emulsions (A) and (B). This process does not have the drawbacks caused by the presence of high contents of alkaline agents, and uses dyeing and/or bleaching compositions having improved lightening properties and that are stable over time, while at the same time remaining at least as effective in terms of the uniformity of the lightening, while at the same time preserving the quality of the keratin fibre. | 01-24-2013 |
Leila Houhou, Montpellier FR
| Patent application number | Description | Published |
|---|---|---|
| 20120020961 | METHODS AND COMPOSITIONS FOR LIVER CANCER THERAPY - The present disclosure provides methods of treating liver cancer and preventing liver cancer recurrence with anti-progastrin antibodies, methods of monitoring treatment efficacy of anti-progastrin therapy for liver cancer, and compositions useful therefore. | 01-26-2012 |
Leila Kaghazian, Los Angeles, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20130125017 | SELECTIVE SENDING OF PORTIONS OF ELECTRONIC CONTENT - A user of a handheld communication device selects in a foreground process portions of an electronic document. In a background process a new document is prepared that comprises the selected portions. The user selects the address for forwarding the new document, and the new document gets sent in a background process. | 05-16-2013 |
Leila Kamoun, Nanterre FR
| Patent application number | Description | Published |
|---|---|---|
| 20110309959 | METHOD FOR IMPROVING THE RESOLUTION AND FOR CORRECTING DISTORTIONS IN A SIGMA-DELTA MODULATOR, AND SIGMA-DELTA MODULATOR IMPLEMENTING SAID METHOD - In a method for improving resolution and for correcting distortions for a sigma-delta modulator, a modulator converts an analog input signal into a secondary output digital signal sampled at a frequency f | 12-22-2011 |
Leila Khatai, Graz AT
| Patent application number | Description | Published |
|---|---|---|
| 20110117281 | AQUEOUS COATING BINDERS FOR CORROSION PROTECTION, WOOD AND CONCRETE - This invention relates to aqueous binders comprising mass fractions of from 70% to 98% of chain-extended epoxy amine adducts A and from 2% to 30% of crosslinkers C that are selected from the group consisting of aminoplast resins, phenol resols, triazine tris-alkyl carbamates, and mixtures of such crosslinking agents, a method of making these binder mixtures, and a method of use thereof in coatings for metals, wood, cardboard, plaster, and concrete. | 05-19-2011 |
Leila Kheirandish-Gozal, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110217719 | METHODS AND KITS FOR DIAGNOSING OBSTRUCTIVE SLEEP APNEA - The presently-disclosed subject matter provides methods and kits for diagnosing obstructive sleep apnea (OSA) in a subject, such as a human child, wherein a biological sample is provided from the subject and the amount of a Urocortin III peptide is determined from the sample. Further provided are methods for diagnosing OSA in a subject wherein the amount of a Urocortin III peptide and one or more peptides selected from a Uromodulin peptide, an Orosomucoid 1 peptide, and a Kallikrein 1 peptide are determined in a biological sample from a subject. | 09-08-2011 |
Leila Koziy, Braintree, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110246424 | AUTOMATED RELOCATION OF IN-USE MULTI-SITE PROTECTED DATA STORAGE - Methods of providing access to data are presented. The method includes providing a storage grid which includes a source chain of storage nodes and a target chain of storage nodes, the source chain including a primary source node and a secondary source node which operates as a data minor of the primary source node, and the target chain including a primary target node and a secondary target node which operates as a data mirror of the primary target node. The method also includes initially storing data on the source chain, the primary source node of the source chain maintaining a primary source copy of the data, and the secondary source node of the source chain maintaining a secondary source copy of the data. The method further includes relocating the data from the source chain to the target chain, the primary target node of the target chain maintaining a primary target copy of the data, and the secondary target node of the target chain maintaining a secondary target copy of the data, access to the data being continuously provided from the storage grid to an external device before, during, and after relocation of the data from the source chain to the target chain. | 10-06-2011 |
Leila Ladani, Logan, UT US
| Patent application number | Description | Published |
|---|---|---|
| 20090308172 | Mechanical Properties Testing Device and Method - A mechanical property testing device and method for reliably measuring strain and fatigue characteristics of material specimens is described. An input electrical signal is applied to create an electric field around a first piezoelectric member. The resultant deformation of the first piezoelectric member transfers a force to the specimen being tested which transfers a force to a second piezoelectric member causing deformation. The deformation of the second piezoelectric member generates an output electrical field which is measured. The stress state of the specimen is calculated from fundamental material constants and the measured output electrical field. | 12-17-2009 |
Leila Masinaei, Norfolk, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20110262554 | COMPOSITIONS FOR REPAIR OF DEFECTS IN OSSEOUS TISSUES, AND METHOS OF MAKING THE SAME - Tissue repair compositions, particularly bone repair compositions, containing demineralized bone fragments and homogenized connective tissues, and methods for making the same. The compositions can be used in the form of an injectable gel, an injectable paste, a paste, a putty, or a rehydratable freeze-dried form. | 10-27-2011 |
Leila Masinaei, Dubai AE
| Patent application number | Description | Published |
|---|---|---|
| 20090162445 | Composition for Repair of Defects in Osseous Tissues - Tissue repair compositions, particularly bone repair compositions, containing demineralized bone fragments and homogenized connective tissues. The compositions can be used in the form of an injectable gel, an injectable paste, a paste, a putty, or a rehydratable freeze-dried form. | 06-25-2009 |
| 20110045044 | COMPOSITIONS FOR REPAIR OF DEFECTS IN TISSUES, AND METHODS OF MAKING THE SAME - Tissue repair compositions, particularly bone repair compositions, containing (a) bone fragments and (b) homogenized connective tissue, and methods for making the same are provided. Some of the inventive tissue repair compositions contain a radioprotectant. The compositions can be used in the form of an injectable gel, an injectable paste, a paste, a putty, or a rehydratable freeze-dried form. Kits for using such tissue repair compositions are also provided. | 02-24-2011 |
Leila Moulay, Valencia ES
| Patent application number | Description | Published |
|---|---|---|
| 20100034954 | NUTRITIONALLY SUITABLE COCOA FOR ANIMAL FEED - The invention relates to a method for obtaining fibre-rich cocoa with low carbon hydrate and methylxanthine contents and resulting cocoa powder which is suitable for animal feed. The inventive method includes the following main steps in which: the whole cocoa beans undergo cleaning, deffating, treatment with alpha-amylase, centrifugation, extraction-washing and subsequent centrifugation, separation, drying and grinding. | 02-11-2010 |
Leila Moulay, Quart De Poblet ES
| Patent application number | Description | Published |
|---|---|---|
| 20090269439 | PROCESS FOR PREPARING A HIGHLY-SOLUBLE COCOA EXTRACT - The invention relates to a method of obtaining a highly-soluble extract from cocoa husk and/or bark. The end product, which is rich in dietary fibre, is ideal for use in chocolate, bread-making, drinks, snacks, diary products and confectionery goods. | 10-29-2009 |
Leila Su, Diamond Bar, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110092695 | CELL CULTURE MODEL FOR ACQUIRED CHEMORESISTANCE OF CHRONIC MYELOGENOUS LEUKEMIA AND RELATED METHODS FOR IDENTIFYING AGENTS TO OVERCOME RESISTANCE - A method of generating a chronic myelogenic leukemia (CML) acquired chemoresistant culture model is provided. Such a method may comprise providing a naïve blast crisis CML cell line; administering/contacting the cell line with a mutation-inducing dose of imatinib; maintaining a culture of the treated cell line for a period of time until the treated cell line relapses and repopulates the culture; and determining the repopulated cell culture is a CML acquired chemoresistant cell line by detecting a BCR-ABL mutation, wherein the acquired chemoresistance is achieved by a BCR-ABL mutation. | 04-21-2011 |
| 20110245304 | RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE - Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme. These inhibitors may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases. | 10-06-2011 |
Leila Telan, Wuppertal DE
| Patent application number | Description | Published |
|---|---|---|
| 20080214602 | N-Biarylamides - The invention relates to N-biarylamides useful for the prophylaxis and/or treatment of impairments of perception, concentration, learning and/or memory, and to processes for preparing them, and pharmaceutical compositions containing them. | 09-04-2008 |
| 20100022537 | I-PHENY 1-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVES AND THEIR USE - This invention relates to novel heterocyclic derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development. | 01-28-2010 |
| 20120157490 | N-BIARYLAMIDES - The invention relates to N-biarylamides useful for the prophylaxis and/or treatment of impairments of perception, concentration, learning and/or memory, and to processes for preparing them, and pharmaceutical compositions containing them. | 06-21-2012 |
Leila Telan, Düsseldorf DE
| Patent application number | Description | Published |
|---|---|---|
| 20100184788 | HETEROCYCLIC DERIVATIVES - The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, and heart failure development. | 07-22-2010 |
Leila Telan, Düsseldorf DE
| Patent application number | Description | Published |
|---|---|---|
| 20100184788 | HETEROCYCLIC DERIVATIVES - The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, and heart failure development. | 07-22-2010 |
Leila Tirichine, Risskov DK
| Patent application number | Description | Published |
|---|---|---|
| 20100031388 | MUTANT HISTIDINE KINASE THAT CONFERS SPONTANEOUS NODULATION IN PLANTS - Formation of nitrogen fixing root nodules in legumes is induced by perception of lipochitin-oligosaccharide signal molecules secreted by compatible | 02-04-2010 |
Leila Tirichine, Levallois-Perret FR
| Patent application number | Description | Published |
|---|---|---|
| 20110078814 | SPONTANEOUS NODULATION IN PLANTS - Formation of nitrogen fixing root nodules in legumes is induced by perception of lipochitin-oligosaccharide signal molecules secreted by compatible | 03-31-2011 |
Leila Zarif, Peymeinade FR
| Patent application number | Description | Published |
|---|---|---|
| 20090215849 | High stability aqueous gels comprising metronidazole and methods for the preparation thereof - A method for preparing highly stable aqueous gels based on metronidazole, well suited for treating such skin conditions as rosacea, acne and dermatitis, entails the successive steps of: | 08-27-2009 |
| 20090312429 | Administration of nepafenac or derivatives thereof for treating dermatological/keratinization disorders - Nepafenac or derivatives thereof are useful for the treatment of dermatological conditions related to a keratinization disorder that may have an inflammatory immunoallergic component, for example rosacea, acne, psoriasis or atopic dermatitis. | 12-17-2009 |
| 20100210994 | DELIVERY OF THERAPEUTICALLY/DERMATOLOGICALLY ACTIVE SPECIES INTO THE SKIN VIA ELECTROPORATION - A regime or regimen for treating a skin disease, disorder or condition afflicting a patient in need thereof includes forming at least one micropore to a predetermined depth through a surface of the afflicted skin of such patient; positioning at least a first electrode on the surface of the afflicted skin electrically coupled to the at least one micropore and a second electrode on the surface of the afflicted skin spaced apart from the first electrode; applying an electrical voltage from the first and second electrodes to produce a desired electroporation in the skin, and further including the step of delivering a biologically active species to the afflicted skin at the at least two micropores formed therein, wherein the biologically active species is therapeutically/dermatologically active against the skin disease, disorder or condition. | 08-19-2010 |
Leila Zarif, Branchburg, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090028904 | Novel cochleate formulations - A process for producing a small-sized, lipid-based cochleate. Cochleates are derived from liposomes which are suspended in an aqueous two-phase polymer solution, enabling the differential partitioning of polar molecule based-structures by phase separation. The liposome-containing two-phase polymer solution, treated with positively charged molecules such as Ca | 01-29-2009 |
Leila Zarif, Cannes FR
| Patent application number | Description | Published |
|---|---|---|
| 20120294901 | NOVEL COCHLEATE FORMULATIONS - A process for producing a small-sized, lipid-based cochleates. Cochleates are derived from liposomes which are suspended in an aqueous two-phase polymer solution, enabling the differential partitioning of polar molecule based-structures by phase separation. The liposome-containing two-phase polymer solution, treated with positively charged molecules such as Ca | 11-22-2012 |